Debu tripathy biography of barack
•
Keeping Patients in Mind: Noted Breast Cancer Researcher Pursues Broad Notion of Personalized Medicine
Debu Tripathy, MD
When a friend died of leukemia during his childhood, Debu Tripathy was shocked. It was not the sort of thing he'd believed could happen to someone so ung. But as Tripathy watched the way the girl's mother reacted to the loss, his disbelief turned to admiration.
"Her mother wrote a book and gave speeches advocating for some of the personal issues that people go through, how a family fryst vatten drawn tillsammans in times of crisis," recalled Tripathy. "I was very moved by how she responded to her daughter's illness and death by doing something so positive."
More than 3 decades later, Tripathy, a world-renowned oncologist and translational researcher who fills several roles at the University of Southern California (USC), Los Angeles, remains deeply interested in the patient experience.
One of a small group of scientists who
•
Debu Tripathy, MD
Professor of Medicine & Chair, Breast Medical Oncology, University of Texas MD Anderson Cancer Center
featured_paragraph
D
Debu Tripathy, MD, is a professor of medicine and chair of the department of breast medical oncology at the University of Texas MD Anderson Cancer Center.
general_content
Dr. Tripathy’s clinical research focuses on evaluating and developing new treatments for breast cancer, specifically those targeting sensitivity and resistance mechanisms to growth factors, endocrine modulators, and cell cycle control pathways. He also investigates biomarkers predicting sensitivity and resistance. Dr. Tripathy has led clinical trials supporting the approval of new biological therapies for breast cancer targeting the HER2 oncogene and cyclin-dependent kinases, both improving patient survival.
Dr. Tripathy has published numerous original translational and landmark clinical research articles in the field of breast cancer. He serves on several edit
•
Distinguished Alumni
Dr. Tripathy’s clinical research focuses on the evaluation and development of novel therapeutics in breast cancer, specifically growth factor receptor pathway targeting as well as biomarkers that predict sensitivity and resistance. He oversees a group of physicians and scientists dedicated to discovering mechanisms of breast cancer cell growth and metastases, as well as biological pathways that drive the